Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 252

1.

Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial.

Krishnan-Sarin S, O'Malley SS, Franco N, Cavallo DA, Tetrault JM, Shi J, Gueorguieva R, Pittman B, Krystal JH.

Neuropsychopharmacology. 2019 Oct 7. doi: 10.1038/s41386-019-0536-z. [Epub ahead of print]

PMID:
31590179
2.

Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study.

Citrome L, O'Malley SS, McDonnell D, Jiang Y, Simmons AC, Berry MP, Dipetrillo LE.

Innov Clin Neurosci. 2019 May 1;16(5-6):15-21.

3.

The Kappa Opioid Receptor Is Associated With Naltrexone-Induced Reduction of Drinking and Craving.

de Laat B, Goldberg A, Shi J, Tetrault JM, Nabulsi N, Zheng MQ, Najafzadeh S, Gao H, Kapinos M, Ropchan J, O'Malley SS, Huang Y, Morris ED, Krishnan-Sarin S.

Biol Psychiatry. 2019 Jun 8. pii: S0006-3223(19)31413-1. doi: 10.1016/j.biopsych.2019.05.021. [Epub ahead of print]

4.

Flavorant-Solvent Reaction Products and Menthol in JUUL E-Cigarettes and Aerosol.

Erythropel HC, Davis LM, de Winter TM, Jordt SE, Anastas PT, O'Malley SS, Krishnan-Sarin S, Zimmerman JB.

Am J Prev Med. 2019 Sep;57(3):425-427. doi: 10.1016/j.amepre.2019.04.004. Epub 2019 Jul 27. No abstract available.

PMID:
31358341
5.

Psychometric evaluation of the Patient-Reported Outcomes Measurement Information System (PROMIS)Nicotine Dependence Item Bankfor use with electronic cigarettes.

Morean ME, Krishnan-Sarin S, Sussman S, Foulds J, Fishbein H, Grana R, O'Malley SS.

Nicotine Tob Res. 2019 Jun 29. pii: ntz095. doi: 10.1093/ntr/ntz095. [Epub ahead of print] No abstract available.

PMID:
31254382
6.

Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general population.

Knox J, Wall M, Witkiewitz K, Kranzler HR, Falk DE, Litten R, Mann K, O'Malley SS, Scodes J, Anton R, Hasin DS; Alcohol Clinical Trials (ACTIVE) Workgroup.

Drug Alcohol Depend. 2019 Aug 1;201:16-22. doi: 10.1016/j.drugalcdep.2019.03.020. Epub 2019 May 29.

PMID:
31174140
7.

Corrigendum to "Comparing cigarette and e-cigarette dependence and predicting frequency of smoking and e-cigarette use in dual-users of cigarettes and e-cigarettes." [Addict Behaviour. 87(2018), 92-96].

Morean ME, Krishnan-Sarin S, O'Malley SS.

Addict Behav. 2019 Oct;97:132. doi: 10.1016/j.addbeh.2019.05.028. Epub 2019 May 31. No abstract available.

PMID:
31155402
8.

Bayesian joint modelling of longitudinal data on abstinence, frequency and intensity of drinking in alcoholism trials.

Buta E, O'Malley SS, Gueorguieva R.

J R Stat Soc Ser A Stat Soc. 2018 Jun;181(3):869-888. doi: 10.1111/rssa.12334. Epub 2017 Nov 6.

9.

Modulation of 'Protective' Nicotine Perception and Use Profile by Flavorants: Preliminary Findings in E-Cigarettes.

DeVito EE, Jensen KP, O'Malley SS, Gueorguieva R, Krishnan-Sarin S, Valentine G, Jatlow PI, Sofuoglu M.

Nicotine Tob Res. 2019 Apr 17. pii: ntz057. doi: 10.1093/ntr/ntz057. [Epub ahead of print]

PMID:
30995302
10.

Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial.

Witkiewitz K, Falk DE, Litten RZ, Hasin DS, Kranzler HR, Mann KF, O'Malley SS, Anton RF.

Alcohol Clin Exp Res. 2019 May;43(5):979-987. doi: 10.1111/acer.14018. Epub 2019 Apr 5.

11.

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.

Falk DE, O'Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, Kranzler HR, Mann KF, Hasin DS, Johnson B, Meulien D, Ryan M, Fertig J; Alcohol Clinical Trials Initiative (ACTIVE) Workgroup.

JAMA Psychiatry. 2019 Apr 1;76(4):374-381. doi: 10.1001/jamapsychiatry.2018.3079.

PMID:
30865232
12.

Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population.

Knox J, Scodes J, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Anton R, Hasin DS; Alcohol Clinical Trials (ACTIVE) Workgroup.

Drug Alcohol Depend. 2019 Apr 1;197:228-235. doi: 10.1016/j.drugalcdep.2019.01.009. Epub 2019 Feb 14.

PMID:
30852375
13.

Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking.

Bold KW, Zweben A, Fucito LM, Piepmeier ME, Muvvala S, Wu R, Gueorguieva R, O'Malley SS.

Alcohol Clin Exp Res. 2019 May;43(5):937-944. doi: 10.1111/acer.13994. Epub 2019 Mar 21.

PMID:
30817018
14.

Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder.

Witkiewitz K, Kranzler HR, Hallgren KA, O'Malley SS, Falk DE, Litten RZ, Hasin DS, Mann KF, Anton RF.

Alcohol Clin Exp Res. 2018 Dec;42(12):2453-2465. doi: 10.1111/acer.13897. Epub 2018 Nov 5.

PMID:
30395350
15.

Presence of High-Intensity Sweeteners in Popular Cigarillos of Varying Flavor Profiles.

Erythropel HC, Kong G, deWinter TM, O'Malley SS, Jordt SE, Anastas PT, Zimmerman JB.

JAMA. 2018 Oct 2;320(13):1380-1383. doi: 10.1001/jama.2018.11187. No abstract available.

16.

Correction: Preferring more e-cigarette flavors is associated with e-cigarette use frequency among adolescents but not adults.

Morean ME, Butler ER, Bold KW, Kong G, Camenga DR, Cavallo DA, Simon P, O'Malley SS, Krishnan-Sarin S.

PLoS One. 2018 Sep 13;13(9):e0204349. doi: 10.1371/journal.pone.0204349. eCollection 2018.

17.

Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population.

Knox J, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Scodes J, Anton R, Hasin DS; Alcohol Clinical Trials (ACTIVE) Workgroup.

Alcohol Clin Exp Res. 2018 Nov;42(11):2256-2265. doi: 10.1111/acer.13884. Epub 2018 Oct 3.

PMID:
30204248
18.

Development and psychometric validation of a novel measure of sensory expectancies associated with E-cigarette use.

Morean ME, Krishnan-Sarin S, Sussman S, Foulds J, Fishbein H, Grana R, Halpern-Felsher B, Kim H, Weaver SR, O'Malley SS.

Addict Behav. 2019 Apr;91:208-215. doi: 10.1016/j.addbeh.2018.08.031. Epub 2018 Aug 31.

PMID:
30197032
19.

A Pilot Clinical Trial of Smoking Cessation Services Implemented in the Workplace for Service Industry Employees.

Bold KW, Kimmel L, Hanrahan TH, Romano D, Rojewski AM, Krishnan-Sarin S, Fucito LM, O'Malley SS.

Am J Health Promot. 2019 May;33(4):516-524. doi: 10.1177/0890117118795987. Epub 2018 Aug 28.

PMID:
30153737
20.

Drinking goals and attainment in a naltrexone trial of young adult heavy drinkers.

DeMartini KS, Foster DW, Corbin WR, Fucito LM, Romano D, Leeman RF, Kranzler HR, O'Malley SS.

J Consult Clin Psychol. 2018 Sep;86(9):765-774. doi: 10.1037/ccp0000323.

Supplemental Content

Loading ...
Support Center